Sign inJoin waitlistJoin the waitlist

Paul Richardson

, Clinical Program Leader and Director of Clinical Research · Mass General Brigham

Credentials: · · ·

History

Jerome Lipper Multiple Myeloma Center · Mass General Brigham
Present
Mass General Brigham
Present

Hematology and Medical Oncology
BAYSTATE ADMINISTRATIVE SERVICES, INC.
1989–1992
Internal Medicine
Beth Israel Deaconess Medical Center
1986–1989
University of London
1982–1986

Research

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Review · The Lancet Oncology · 2014 · 3,783 citations
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Review · The Lancet Oncology · 2016 · 2,602 citations
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
Cell · 2011 · 2,410 citations

Ken Anderson
444 papers
Nikhil Munshi
191 papers
Jacob Laubach
167 papers
Sagar Lonial
100 papers
NR
Noopur Raje
97 papers · 19 as a resident
RS
Robert Schlossman
95 papers
Irene Ghobrial
71 papers · 10 as a fellow
Shaji Kumar
57 papers
Sundar Jagannath
57 papers
SR
Sundararajan Rajkumar
53 papers
Robert Orlowski
49 papers
Peter Voorhees
36 papers

Clinical trials

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
Principal investigator · Unknown · Phase 1, Phase 2
Prolexys Pharmaceuticals
2012–2014
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Principal investigator · Active not recruiting · Phase 3
Paul Richardson, MD
2010–2026
Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
Principal investigator · Terminated · Phase 3
AEterna Zentaris
2009–2013
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Principal investigator · Completed · Phase 3
Jazz Pharmaceuticals
2007–2016